No significant correlations for pairs of clinicopathological characteristics (PSA/age, PSA/Gleason score, age/Gleason score) were observed, which confirms results of many authors [74,75] and indicates the need to look for new biomarkers to facilitate the diagnosis of prostate cancer. This evidence concerns the gene KLK3 and prostate cancer.